Stock Scorecard
Stock Summary for IRIDEX Corp (IRIX) - $1.13 as of 10/7/2025 2:22:32 AM EST
Total Score
10 out of 30
Safety Score
12 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for IRIX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for IRIX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for IRIX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for IRIX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for IRIX (12 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for IRIX
Financial Details for IRIX
Company Overview |
|
|---|---|
| Ticker | IRIX |
| Company Name | IRIDEX Corp |
| Country | USA |
| Description | IRIDEX Corporation (IRIX) is a leading ophthalmic medical technology company specializing in the development and commercialization of innovative therapeutic laser systems and associated delivery devices designed to treat serious eye diseases. With a strong focus on improving patient outcomes in ophthalmology, the company offers a comprehensive range of consumable instrumentation that supports advanced ocular treatments. Headquartered in Mountain View, California, IRIDEX is strategically positioned in a growing market, leveraging its expertise to introduce groundbreaking solutions for vision preservation and restoration. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/11/2025 |
Stock Price History |
|
| Last Day Price | 1.13 |
| Price 4 Years Ago | 6.11 |
| Last Day Price Updated | 10/7/2025 2:22:32 AM EST |
| Last Day Volume | 247,837 |
| Average Daily Volume | 85,282 |
| 52-Week High | 1.95 |
| 52-Week Low | 0.78 |
| Last Price to 52 Week Low | 44.87% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 44.24 |
| Sector PE | 41.70 |
| 5-Year Average PE | -6.29 |
| Free Cash Flow Ratio | 2.83 |
| Industry Free Cash Flow Ratio | 37.96 |
| Sector Free Cash Flow Ratio | 30.25 |
| Current Ratio Most Recent Quarter | 1.96 |
| Total Cash Per Share | 0.40 |
| Book Value Per Share Most Recent Quarter | 0.00 |
| Price to Book Ratio | 331.20 |
| Industry Price to Book Ratio | 3.99 |
| Sector Price to Book Ratio | 32.02 |
| Price to Sales Ratio Twelve Trailing Months | 0.39 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.50 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.22 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 16,992,300 |
| Market Capitalization | 19,201,299 |
| Institutional Ownership | 15.83% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 1.12% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 6.90% |
| Reported EPS 12 Trailing Months | -0.32 |
| Reported EPS Past Year | -0.16 |
| Reported EPS Prior Year | -0.54 |
| Net Income Twelve Trailing Months | -5,447,000 |
| Net Income Past Year | -8,910,000 |
| Net Income Prior Year | -9,570,000 |
| Quarterly Revenue Growth YOY | 7.40% |
| 5-Year Revenue Growth | 2.30% |
| Operating Margin Twelve Trailing Months | -6.93% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 6,778,000 |
| Total Cash Past Year | 2,387,000 |
| Total Cash Prior Year | 7,034,000 |
| Net Cash Position Most Recent Quarter | 3,103,000 |
| Net Cash Position Past Year | 1,383,000 |
| Long Term Debt Past Year | 1,004,000 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 3,675,000 |
| Equity to Debt Ratio Past Year | 0.68 |
| Equity to Debt Ratio Most Recent Quarter | 0.62 |
| Total Stockholder Equity Past Year | 2,097,000 |
| Total Stockholder Equity Prior Year | 9,522,000 |
| Total Stockholder Equity Most Recent Quarter | 6,059,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -5,893,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.35 |
| Free Cash Flow Past Year | -7,298,000 |
| Free Cash Flow Prior Year | -6,854,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.03 |
| MACD Signal | -0.03 |
| 20-Day Bollinger Lower Band | 0.82 |
| 20-Day Bollinger Middle Band | 1.15 |
| 20-Day Bollinger Upper Band | 1.48 |
| Beta | 0.60 |
| RSI | 49.35 |
| 50-Day SMA | 1.96 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 2.38 |
System |
|
| Modified | 10/7/2025 2:23:19 AM EST |